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1. Introduction 
The subsynaptic membrane fragments prepared 
from Torpedo electric organ are composed of a few 
discrete polypeptide entities (reviewed [l-3]). The 
predominant chain of app. mol. wt 40 000 (40 k) is 
covalently labelled by affinity reagents specific for 
the acetylcholine receptor site and therefore carries 
this site [4-lo]. The NH2 terminal sequence of its 
first 20 amino acids has been established in the case of 
Torpedo marmorata receptor [ 1 l] and confirmed 
with Torpedo californica [ 121. The 43 k polypeptide 
is a peripheral protein which is released from the 
subsynaptic membrane by treatment at pH 11. Its 
alkaline extraction does not significantly change the 
known regulatory properties of the ACh receptor 
protein [ 13-161 but alters its thermal stability [ 171 
and its rotational [ 18-211 and translational [22] 
diffusion. Most likely, the 43 k protein plays a ‘struc- 
tural’ role in maintaining the ACh receptor protein in 
a highly immobilized and stable aggregated form in 
the subsynaptic membrane. 
Minor polypeptide components of app. mol. wt 
50k,57k,66k [23-251 are also encountered in the 
ACh-receptor rich membranes and copurify with the 
a-bungarotoxin labelled ACh-receptor solubilized by 
non-denaturing detergents. A photoaffinity derivative 
of the local anesthetic trimethisoquin, 5-azido-[3H]- 
trimethisoquin (5-A[3H]T) [26] labelled bands of 
Abbreviations: ACh, acetylcholine; 5-A[“H]T, 5-azido-[“HI- 
trimethisoquin; SDS, sodium dodecyl sulfate; MPTA, 
44N-maIeimido)phenyltrimethylammonium; EDTA, ethyl- 
enediaminetetraacetic a id; EGTA, ethyleneglycol-bis-(p- 
aminoethyl ether) N,N’-tetraacetic acid 
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app. mol. wt 50 k and 66 k [27]. This labelling is 
inhibited by histrionicotoxin or unlabelled local anes- 
thetics; it is enhanced by carbamylcholine and the 
effect of carbamylcholine is blocked by a-bungaro- 
toxin [27]. The criteria for a selective attachment of 
5-A[3H]T to the site for the non-competitive blockers 
of the permeability response thus seem fulfilled. 
To explain the rather paradoxical labelling by 
5-A [3H] T of two polypeptide chains instead of one, 
three possibilities were considered: 
(i) The site for non-competitive blockers is not 
carried by the 50 k or 66 k chain; however, these 
chains lie in the vicinity of the binding site and 
become preferentially labelled since they present 
chemical groups with which the nitrene group of 
5-A[3H]T reacts. 
(ii) The 50 k and 66 k chains are different but carry 
binding sites for noncompetitive blockers with 
similar reactivities. 
(iii) The 50 k chain labelled by 5-A[3H] T derives 
from the 66 k chain by proteolysis. 
These results show that the third alternative is the 
correct one. Under conditions which limit proteolysis, 
5-A [ 3H] T selectively labels the 66 k polypeptide 
chain. 
2. Materials and methods 
2.1. Preparation of ACh-receptor rich membranes 
from Torpedo marmorata electric organ 
ACh-receptor rich membranes were purified from 
freshly dissected electric organ of T. rnarmorata, 
except when otherwise noted. Membranes were 
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purified as in [28]. To investigate the effect of 
protease inhibitors the following buffer (PI) was used: 
50 mM Tris-HCl (pH 7 5 at 20°C) 3 mM EDTA, 
1 mM EGTA, 0.1 mM phenyl-methyl-sulfonyl fluoride 
(PMSF), 5 units/ml aprotinine, and 0.5 pg/ml pep- 
statin. 
2.2. Affinity labelling of the binding site for non- 
competitive blockers by tritiated 5-azido-tri- 
methisoquin 
200 ~1 of ACh-receptor rich membranes (15-20 PM 
‘251-labelled a-bungarotoxin sites) were extracted at 
pH 11 according to [ 131 and centrifuged for 30 min 
at 27 000 rev./min in a Beckman Ti 30 Rotor. The 
pellet was resuspended in 200 1.11 Torpedo saline solution 
(250 mM NaCl, 5 mM KCl, 4 mM CaCla, 2 mM MgCl* 
and 5 mM Na-phosphate, pH 7.5) and recentrifuged 
at full speed in a Beckman airfuge for 1 min. The final 
pellet was resuspended to 100 1.11 with Torpedo saline 
solution. Carbamylcholine was added to IO4 M 
(final) followed by the addition of 5-A [ 3H] T
(5 X 10e6 M, final) in the dark. The reaction chamber 
was flushed with Na; and the sample equilibrated for 
15 min in the dark. The mixture was then irradiated 
for 5 min with vigorous stirring under Nz with a 
Mineralight shortwave ultraviolet lamp (Ultraviolet 
Products). Following irradiation, the membranes were 
washed twice by centrifugation in a Beckman airfuge 
and resuspended in PI buffer. 
2.3. Sucrose gradient putification of the ACh-receptor 
protein 
The 5-A[3H] T-labelled membranes were diluted to 
450 ~1 with PI buffer. /3-mercaptoethanol was added 
to 0.6% (v/v) final cont., followed by 40% (w/v) Na- 
cholate to 3%. The sample was then loaded on an 
11.5 ml 5-20% (w/v) sucrose gradient containing 1% 
Na-cholate and 0.6% /3-mercaptoethanol in PI buffer. 
The gradients were centrifuged for 16 h at 33 000 
rev./minin a Beckman SW 41 rotor at 4°C. Sevendrop 
fractions were collected from the bottom of the tube. 
Each fraction was assayed for o-toxin binding activity 
with ‘2SI-labelled a-bungarotoxin and for 5-A[3H]T 
by counting a 25 ~1 aliquot in 4 ml of Bray’s solution. 
Under these conditions, all ACh-receptor was present 
as a 9 S monomer. In all cases, the profiles of 
12’1-labelled o-bungarotoxin binding activity and 
5-A [ 3H] T labelling were superimposable along the 
sucrose gradient. 
2.4. Affinity chromatography purification of the 
A Ch-recep tor protein 
ACh-receptor protein was purified using a 2 ml 
erabutoxin B-Sepharose 4B affinity column equili- 
brated in PI buffer supplemented with 0.1% Triton 
X-100 and 0.6% /3-mercaptoethanol. Membranes solu- 
bilized in 3% Triton X-100 were cycled through the 
column for 3 h. The column was then washed with 
100 ml equilibration buffer containing 1 M NaCl. Fol- 
lowing the wash, the column was equilibrated with 
the equilibration buffer supplemented with 1 M car- 
bamylcholine and incubated overnight to elute the 
ACh-receptor. All purification steps were performed 
at 4°C. 
2.5. Polyacrylamide gel electrophoresis 
Two polyacrylamide gel systems, that are modifi- 
cations of the system in [29], were used here. Both 
systems contained 10% acrylamide ;however, the 
highly crosslinked system 1 contained 0.26% bisacryl- 
amide and system 2 contained 0.13% bisacrylamide. 
The standard system 2 was described in [5]. 
Sample preparation, fluorography and gel scanning 
were done as in [27] except that films for fluorog- 
raphy were preflashed to an absorbance of 0.2 [30]. 
For quantitation of the radioactivity in each band, 
appropriate sections of the stained and dried gel were 
cut out and counted in a scintillation medium con- 
taining 900 ml toluene/PPO/POPOP, 100 ml tissue 
solubilizer and 20 ml NH40H (4 M) after a 2 day 
incubation at room temperature. Except where 
otherwise noted, samples were not heated prior to 
loading on the gel. 
2.6. Chemicals 
5-Azido-dimethisoquin was a gift of Gilles Waksman 
and Bernard Roques and was prepared as in [26]. 
5-A [3H] T was synthesized from 5-azido-dimethiso- 
quin using [3H]methyliodide at the CEA, Saclay, 
Service des Molecules Marquees. 1251-labelled 
ol-bungarotoxin was purchased from NEN. Aprotinine, 
PMSF, and pepstatin were obtained from Sigma; 
acrylamide, bisacrylamide and TEMED were products 
of Kodak. 
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3. Results and discussion 
3.1. Effect of protease inhibitors on the pattern of 
polypeptide chains labelled by S-azido-/3H]tri- 
methisoquin 
The contribution of proteolysis to the pattern of 
chain(s) labelied by 5-AC3H]T was tested in the 
following manner. ACh-receptor rich membranes 
were prepared from fresh electric organ in the presence 
or absence of a cocktail of protease inhibitors and 
chelating agents (section 2)labelled by 5-A[3H]T and 
solubilized by Na-cholate or Triton X-100. The recep- 
tor protein was then purified in the presence of PI 
buffer. 
First, the distribution of 5-A[3H]T and of r2’I- 
labelled a-bungarotoxin labelling were compared 
during the purification on sucrose gradient after 
dissolution by Nacholate. Fig.1 shows that the profile 
oorrou 
FRACTION 
TOP 
Fig.1. Distribution of 5-A[sH]T and cu-bungarotoxin binding 
activity on a sucrose density gradient. Membranes were 
labelled with S-A[“H]T in the presence of carbamylcholine, 
solubilized in Na-cholate, and centrifuged for 16 h in a 5 -20% 
sucrose gradient containing 0.6% p-mercaptoethanol and 1% 
Na-cholate (see section 2). Fractions were counted for ‘H to 
reveal the 5-A[3H]T label (o---o) and assayed for toxin 
binding activity with “‘1-labelled ol-bungarotoxin (m-m). 
of 3H and “‘1 labelling superimposed almost exactly. 
In other words, the component labelled by 5-A [ 3H] T 
is strongly bound, or belongs to, the detergent- 
extracted receptor protein labelled by the o-toxin. 
Then, the patterns of polypeptide chains given by 
the preparations of receptor prepared in the presence 
and in the absence of protease inhibitors were investi- 
gated by electrophoresis in SDS in a highly crosslinked 
(fig.2A-D) and standard (fig.2E-H) systems of poly- 
acrylamide gels (see section 2). 
The receptor purified in the presence of protease 
inhibitors yielded, in the two gel systems, the four 
characteristic bands stained by Coomassie blue of 
app. mol. wt 40 k, 50 k, 57 k and 66 k (fig. 2A, E). 
In both gel systems, the 66 k band was, of these four, 
the only one labelled by 5-A[3H]T in the presence of 
carbamylcholine (fig2B, F). 
On the other hand, the pattern of bands given by 
the receptor protein prepared in the absence of 
protease inhibitors was always more complex. In the 
highly crosslinked gel system, a band positioned slightly 
below the 50 k band, that will be referred to as bis 
50 k, and a distinct smear above the 40 k band were 
observed in addition to the already mentioned four 
bands (fig.2C). The corresponding fluorograms 
(fig.2D) indicated that both the 66 k and the bis 50 k 
bands were labelled by 5-A[3H]T. In addition, the 
Coomassie blue staining intensities of the 66 k, 57 k 
and 50 k bands and the 5-A[3H]T labelling of the 
66 k band appeared fainter than what was observed 
with the receptor protein purified in the presence of 
protease inhibitors. The simplest interpretation of 
these data is that the bis 50 k band results from the 
proteolytic degradation of the 66 k chain. 
In the standard gel system 2 (fig.2E-H), the 
receptor protein prepared in the absence of protease 
inhibitors gave the standard four bands found in the 
presence of protease inhibitors but, in addition, a new 
band of app. mol. wt 45 k; moreover, the 66 k, 57 k 
and 50 k appeared again fainter. In this slot, and in 
agreement with [27], the 5-A[3H]Tlabellingcoincided 
with the Coomassie blue stained band of app. mol. wt 
50 k. Taking into account the information given by 
the highly crosslinked gels, we conclude that, in the 
standard gel system, the 50 k band is composed of 
the native 50 k chain superimposed on the bis 50 k 
chain which appears to be a degradation product of 
the native 66 k chain. 
Examination of the same gel slot (fig.2G) also 
showed that the appearance of the 45 k band coin- 
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Fig.2. Gel patterns given by the ACh-receptor protein purified from membranes prepared in the presence and in the absence of 
protease inhibitors. A-D are highly crosslinked system 1 polyacrylamide gels in SDS; E-H are standard system 2 gels (see section 2). 
The Coomassie blue stain of ACh-receptor purified with protease inhibitors is shown in A, E, and the corresponding fluorograms 
of 5-A[sH]T labelling in B, F. The Coomassie blue staining of ACh-receptor purified without protease inhibitors is shown in C, H, 
and the corresponding fluorograms in D, H. Because of the anomalous behaviour of some of the chains on the two gel systems, 
nomenclature derived from the comparison of the chains with protein of known mol. wt in the standard gel system 2 will be used 
exclusively. The four major bands in E will be referred to as 40 k, 50 k, 57 k and 66 k dalton peptides. The band between the 40 k 
and 50 k peptides in G will be referred to as the 45 k peptide; and the band below the 50 k chain in C, which comfrates with the 
50 k chain in G, will be referred to as the bis 50 k peptide. The minor peptides below the 40 k chain in C and G are degradation 
products of the 40 k chain as they can be labelled with [ 3H]MPTA, an affinity reagent for the ACh binding site 151. 
tided with a quantitative decrease of intensity of the 
57 k band. Most likely, the 45 k band, which, in the 
highly crosslinked gels, gave only a smear above the 
40 k band resulted also from the proteolysis of the 
57 k polypeptide. 
3.2. Causes for irreproducibility of the pattern of 
chains labelled by 5-azido-[ ‘H] trirnethisoquin 
32.1. Freezing the electric organ 
Frozen electric organ has been used co~only as 
biological material to purify the ACh-receptor protein 
]g 3 I ,321. However, freezing and thawing of the tissue 
might release intracellular proteases which would 
attack the receptor protein in situ before blocking of 
the proteases. 
To test this point, a freshly excised electric organ 
was frozen in liquid nitrogen, thawed to room tem- 
perature and homogenized in the presence of protease 
~hibitors to purify the ACh-receptor-rich membranes. 
In fig.3B, is presented a scan given by a preparation 
of receptor protein purified from these membranes 
after electrophoresis in the standard gel system 2. The 
height of the peak given by the 57 k band appeared 
smaller and that given by the 45 k band higher than 
those of the correspon~g chain in the control prepa- 
ration of receptor protein purified from fresh electric 
tissue. In addition, a larger quantity of sS-A[~H]T was 
found in the bis 50 k band than in the corresponding 
33 
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region of the control (fig.3C, D). Thus, the prepara- 
tion of ACh-receptor from frozen electric tissue 
results in the proteolytic degradation of the 57 k and 
66 k chains even though all the subsequent steps, 
starting from the homogenization, had been carried 
out in the presence of protease inhibitors. 
3 2.2. Presence of Ca2+ 
The chelating agent EDTA has been used in 
[8,32-341 to prevent proteolysis during the prepara- 
tion and purification of the receptor protein. To test 
for the presence of a Ca2+-sensitive protease, 
ACh-receptor-rich membranes, purified in the presence 
of protease inhibitors and chelators, were solubilized 
in the presence of Ca2’ and the receptor protein 
purified from these membranes in the presence of the 
PI buffer (with PMSF, aprotinin and pepstatin) 
except that EDTA and EGTA were replaced by 4 mM 
CaC12. Fig. 4A shows that, under these conditions, 
the 57 k and 66 k were degraded. On the other hand, 
when an excess of Ca2+ was added to the receptor 
protein after purification under the standard condi- 
tions (see section 2), no degradation was observed 
after 16 h incubation at 4°C. A Ca”dependent 
protease, resistant to PMSF, aprotinin and pepstatin 
is therefore present in the homogenate of electric 
organ and copurifies with the ACh-receptor-~eh 
membranes; however, this protease is removed by the 
purification of the detergent-extracted receptor. 
3 2.3. Heating the sample before gel etectrophoresis 
in SDS 
When the sample of purified receptor was heated 
for 3 min at 100°C in a medium containing 2% SDS 
and 0.1% Triton X-100, the pattern of bands stained 
with Coomassie blue appeared strikingly different 
(fig.48). As described in [ 161, the height of the 40 k 
band decreased and gave a smear below the 40 k band 
which was still labelled by the affinity reagent of 
Fig.3. Effect of freezing and thawing of the electric organ on 
the Coomassie blue staining of ACh-receptor purified by 
affinity chromatography in the presence of protease inhibitors. 
The gel scans correspond to the following samples: (A) 
control, ACh-receptor labelled with 5-A[sH]T and purified in 
the presence of protease inhibitors; (B) fluorogram of (A); 
(C) same as (A) except that the ACh-receptor was prepared 
from electric tissue pm-frozen and thawed; (D) fhrorogram 
of(C). 
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Fig.4. Consequences on the polypeptide pattern of the ACh- 
receptor protein of the presence of Ca’+ during purification 
and of sample heating before loading on gels. (A) ACh-recep- 
tor purified in the presence of Ca’+ + protease inhibitors; and 
(B) same as fig. 3(A) but the ACh-receptor sample was heated 
in the presence of SDS for 3 min at 100°C. All samples were 
run on standard gel system 2. 
the ACh-receptor site [3H]MPTA [S]. A band at app. 
mol. wt 60 k was observed in addition to the 57 k 
band which decreased in height. In the preparation of 
receptor purified in the absence of protease inhibitors, 
the 45 k chain was no longer present (not shown). 
4. Conclusion 
When the ACh-receptor protein is purified from 
fresh electric tissue, in the presence of protease inhib- 
itors (including chelating agents), and analyzed by 
SDS gel electrophoresis without heating the sample, a 
reproducible pattern of polypeptide bands is obtained. 
Those bands include: 
(1) The 40 k chain which is labelled by [ 3H] MPTA 
and therefore carries the ACh-receptor site [ 1,2]; 
(2) The 66 k which chain is labelled by the covalent 
local anesthetic 5 -A [3H]T under conditions where 
it attaches selectively to the site for noncompeti- 
tive blockers (in the presence of cholinergic 
agonist). 
These results indicate that the 66 k chain, like the 
40 k chain, is functionally and/or topographically 
related to the molecular device involved in the regu- 
lation of ion translocation by ACh. The 66 k chain 
might carry the site for non-competitive blockers and 
therefore be an integral part of the ACh-regulator. 
However, it may be present in the close vicinity of this 
site (which would then be carried by another chain, 
e.g., the 40 k polypeptide) and possess amino acid 
side group(s) with which the nitrene residue of 
5-A[‘H]T would preferentially react. Experiments 
are now designed to distinguish between these two 
alternatives. 
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